Our Editorial Board Members work closely with our in-house editors to ensure that all manuscripts are subject to the same editorial standards and journal policies. Editorial Board Members are active researchers recognized as experts in their field. Our Editorial Board Members handle manuscripts within their areas of expertise, overseeing all aspects of the peer review process from submission to acceptance.
Research interests: Cardiovascular diseases; Type 2 diabetes; Mendelian randomization; Alcohol; Epidemiology
Ryan Au Yeung (MPH (HKU), PhD (HKU)) is currently an Assistant Professor at the School of Public Health, LKS Faculty of Medicine, The University of Hong Kong. He is interested in the use of Mendelian randomization to identify causes and consequences of cardiovascular diseases and type 2 diabetes, and to explore drug reposition opportunities. His earlier research focused on exploring the causal role of alcohol in cardiovascular diseases and mental health using ALDH2 polymorphism in a Southern Chinese Biobank (Guangzhou Biobank Cohort Study). His recent work involves the use of UK Biobank and summary statistics from genome wide association studies to explore pleiotropic effects of commonly prescribed medications in cardiovascular diseases and diabetes (e.g. metformin). With the COVID-19 pandemic, he is also using Mendelian randomization to explore determinants (e.g. glycaemic traits) contributing to COVID-19 susceptibility. Ryan Au Yeung is currently one of the academic leads of the “Children of 1997” birth cohort in Hong Kong, where he is responsible for curating the genomic and metabolomic data. Webpage.
Research interests: Cardiovascular diseases, nutritional epidemiology, intervention studies
Engelbert trained and practices medicine in Ghana. He proceeded to complete an MSc in epidemiology in the University of the Witwatersrand in Johannesburg, South Africa followed by a PhD in clinical epidemiology from the University Medical Center Utrecht of Utrecht University in the Netherlands. His main research interests are broadly cardiovascular diseases and early life exposures that increase risk of CVD. He also has expertise in nutritional epidemiology and clinical trials. Webpage.
Research interests: Cardiovascular Diseases; Atrial Fibrillation; Epidemiology; Systematic Review
Dr. Giulio Francesco Romiti is a Medical Doctor from Rome, Italy, where he obtained his medical degree at Sapienza - University of Rome. His research activities and expertise are related to clinical research in the broad field of cardiovascular disease, with a particular focus on atrial fibrillation. His research interests also include evidence synthesis. He also serves as a peer reviewer for several medical journals. Webpage.
Research interests: Obesity, Hypertension, Cardiovascular disease, Lifestlyle, Tobacco, Children, Women
Dr. Bo Xi is a professor at the School of Public Health, Cheeloo College of Medicine, Shandong University. He is the director of Children Cardiovascular Research Center of Shandong University. He is the winner of National Science Foundation for Outstanding Youth in 2017 and the winner of the 15th China Youth Science and Technology Award in 2018. His research mainly focuses on epidemiology of childhood obesity, hypertension and cardiovascular risk factors. He has presided over 5 national projects. He has published over 50 English papers, including papers on BMJ, Circulation, JACC, Diabetes Care and Lancet Global Health. Dr. Bo Xi currently serves as the member of the National Expert Committee on cardiovascular diseases, the member of Chinese Preventive Medicine Association-Childhood Chronic Disease Prevention and Management, the youth member of the Epidemiology Branch of the Chinese Preventive Medicine Association, and the corresponding editor of the Chinese Journal of Epidemiology. Dr. Xi is also the peer reviewer of several international top journals including BMJ, Ann Intern Med, JACC, and Lancet Public Health. Webpage.
Research interests: Cardiovascular diseases; Heart failure; Cardiac Hypertrophy; Myocardial infarction; Exercise training; Biomarker; Extracellular vesicles; Non-coding RNAs
Junjie Xiao is currently a Professor at Shanghai University. He is the Vice Dean of Medical School and also the Vice Dean of School of Life Science at Shanghai University. He obtained the National Science Foundation for Outstanding Youth in 2017. He is also the Associate Editor of Journal of Cardiovascular Translational Research, Editorial Board of Journal of Sport and Health Science, Social Media Editor of Journal of Molecular and Cellular Cardiology, etc. He is the author or co-author of many scientific articles, including Circulation, Circulation Research, Cell Metabolism, Nature Communications, Annual Review of Genomics and Human Genetics, and BMC Medicine. He has been the reviewer of Physiological Reviews, Circulation Research, Cell Reports Medicine, Hypertension, Journal of the American College of Cardiology, Molecular Therapy, etc. He obtained 2018 and 2019 Peer Review Awards (Top 1% in Field, Publons). His major research interest is heart failure and exercise training, especially using exercise as a platform to identify novel targets for enhancing cardiac regeneration and combating cardiovascular diseases. Webpage.
Research interests: Irritable bowel Syndrome, Functional Dyspepsia, Constipation, FGIDs, DGBIS, Food intolerance, SIBO, Diarrhoea
Dr. Kewin Siah is a gastroenterologist specialised in Functional Gastrointestinal Diseases (FGID). He completed his specialist training at National University Hospital and underwent further colonoscopy training at Kyoto Prefectural University of Medicine in Japan, as part of the JSGE research fellowship award. He also received the NMRC award to study Irritable Bowel Syndrome (IBS) in Oppenheimer Neurobiology of Stress Centre in UCLA. He is currently the Director of the Gastro Motility Lab and the disease-lead of a multi-disciplinary IBS Clinic in NUH.
Dr. Siah is an assistant professor of the Department of Medicine, Yong Loo Lin School of Medicine. He has been regularly speaking at various local and regional conferences on FGID, and has had multiple publications in international peer-reviewed journals. He was also awarded the best reviewer of year 2020 by Journal of Neurogastroenterology & Motility. He is now the Secretary General of Asian Neurogastroenterology and Motility Association, President of Singapore’s IBS Support Group and Executive Committee of National Foundation Digestive Disease. Webpage.
Research interests: disorders of gut-brain interaction, functional gastrointestinal disorders, irritable bowel syndrome, chronic constipation, dyssynergic defecation, gastroparesis, gastrointestinal motility disorders, functional diarrhea
Andrea Shin, M.D., is an Assistant Professor at Indiana University in Indianapolis, Indiana within the Division of Gastroenterology and Hepatology with a special interest in gastrointestinal motility and functional gastrointestinal disorders. She received her medical degree from Indiana University School of Medicine and completed her internal medicine residency at Indiana University School of Medicine. She then earned a master’s degree in clinical and translational research while training as a research fellow under the mentorship of Michael Camilleri, M.D., at Mayo Clinic in Rochester, Minnesota, followed by completion of a clinical fellowship in gastroenterology and hepatology at Indiana University. She is a member of several organizations including the American Gastroenterological Association (AGA), American College of Gastroenterology (ACG) and American Neurogastroenterology and Motility Society (ANMS).
Prior to receiving her medical degree, she completed her undergraduate studies at Indiana University in Bloomington, Indiana earning a B.S. in biology and a B.A. in Spanish. She received the Arthur Metz scholarship for her undergraduate studies and was an honorary member of Phi Eta Sigma.
Dr. Shin specializes in the care of patients with functional gastrointestinal and motility disorders. Her research focus relates to her clinical expertise and focuses on developing novel diagnostic and therapeutic approaches to treating functional gastrointestinal disorders such as irritable bowel syndrome (IBS). Specific research interests include study of the role of the microbiome, metabolome, diet and psychological distress in IBS, chronic constipation and functional diarrhea. She is a prior recipient of an institutional career-development award (KL2) and a current recipient of a K23 career development award through the National Institutes of health. Webpage.
Global, Public and Environmental Health
Research interests: Evidence-Based Practice; Primary Care; Low value care; Overdiagnosis; Non-communicable Diseases; Clinical Epidemiology
Loai is a Postdoctoral Research Fellow at the Institute for Evidence-Based Healthcare. His research expertise includes evidence synthesis, evidence-based practice, healthcare services, and primary care. He is a medical doctor (MD) from Palestine and completed a Master’s degree in clinical epidemiology at Ludwig Maximilian University of Munich in Germany, followed by a PhD degree in evidence-based practice from Bond University, Australia. Webpage.
Research interests: Alcohol; coronary heart disease; stroke; small vessel disease; Mendelian randomization; GWAS
Steven is an Epidemiologist based within the Stroke Research Group at the University of Cambridge with an interest in cardiovascular disease and related conditions.
His work utilises genome-wide association studies (GWAS) alongside bioinformatic approaches to obtain insights in disease aetiology. This includes applying techniques such as Mendelian randomization to prioritise therapeutic targets and inform clinical or public health decision making.
More widely, he has an interest in individual participant data meta-analysis, the use of electronic health records in medical research, the application and integration of various “-omic” technologies (e.g. metabolomics, proteomics, phenomics), machine learning and modelling of longitudinal data. Webpage.
Research interests: Epidemiology, Systematic reviews, Meta-analysis, Clinical Trials, Metabolic syndrome, Diabetes, Hypertension, Cardiovascular risk factors, Dyslipidemias, Obesity, Pulmonary Hypertension, HIV, hepatitis, Tuberculosis, Public Health, Global Health
Jean Joel is a medical doctor and researcher from Cameroon. It is an expert in epidemiology, clinical trials, and systematic reviews with focus on infectious diseases and non-communicable diseases and the interplay between these two conditions in the global context. He authored more than a hundred of papers in high-impact peer-reviewed journals. In his free time, Jean Joel spends a lot of time with his family playing video games and basketball. Webpage.
Research interests: Type 2 diabetes, venous thrombosis, genome-wide association studies, metabolomics study, twin modeling, mental health (personality research)
Ruifang Li (a.k.a. Ruifang Li-Gao for publications) was originally trained as a computer scientist and bioinformatician (BSc and MSc). She has been working as a research assistant in the area of chemoinformatics (at Bonn University, Germany) and neuroscience (at Max Planck Institute for Human Cognitive and Brain Sciences, Germany) from 2010 till 2014. From 2014 to 2020, she obtained her PhD degree in Clinical Epidemiology at Leiden University Medical Center (LUMC), the Netherlands. During her PhD, her main research focus was on untangling the metabolic and genetic basis of metabolic and cardiovascular diseases by using large-scale population based cohort studies. Currently, she worked as a postdoc at Tilburg University and the Vrije Universiteit Amsterdam, the Netherlands. She aims to use multi-omics approach to investigate the biological mechanisms of Type D (distressed) personality, and its relationship to diseases. She also acts as an associate editor (and statistical reviewer) for the journals of BMC Endocrine Disorders and BMC Cardiovascular Disorders since October 2020. Webpage.
Research interests: Global Health, Malaria, RSV, Child Health, Childhood Immunization, Health Access, Population health
Emelda heads the Population Health Unit within the KEMRI-Wellcome Trust Research Programme in Kenya which aims to understand determinants of health transitions and vulnerabilities at fine scales across Africa and works to embed the use of data for decision-making by national ministries. Emelda has 20 years of Population and Public Health research experience. Deep expertise in Impact evaluation, epidemiology, public health, statistics, data analytics and operations research with a focus on evaluations and contribution analysis. Prior to this position Emelda was a Program Officer/Gates Fellow within the Global Health Team at the Bill and Melinda Gates foundation. She has worked on evaluating the public health impact of malaria control, on evaluating anti-retroviral treatment programs while at IHME and on developing strategies for primary health care at Philips Research Africa. Emelda has a PhD in Epidemiology, has been awarded two internationally competitive Wellcome Trust (UK) Fellowships and is widely published. Webpage.
Research interests: Life course epidemiology; public health; general population studies; longitudinal studies; musculoskeletal disorders; rehabilitation medicine; osteoporosis.
Petteri obtained his MD-PhD degree at the University of Oulu, Finland. His PhD dissertation in 2017 addressed the life-course determinants of vertebral size, a known contributor to vertebral fracture risk. Alongside clinical work at various medical institutions, Petteri currently serves as a post-doc fellow at the University of Oulu, with diverse research activity in life-course epidemiology and public health. His particular interest is in general population studies with longitudinal data on demographic, psychosocial, behavioural and clinical dimensions. Webpage.
Research interests: Epidemiology, Public Heath, HIV/AIDS and Other Sexually Transmitted Infections, Pre-exposure prophylaxis for HIV, Evidence-based Medicine, Nutrition and Infectious Diseases, Women's and Children's Health, and Inequalities in Health
M Pereira is Epidemiologist and adjunct professor of HIV/AIDS Epidemiology and Other Sexually Transmitted Infections. Bachelor's Degree in Nutrition from the Federal University of Recôncavo da Bahia (2011). Master Degree in Food, Nutrition and Health – Federal University of Bahia (UFBA), Salvador (Brazil). Doctor in Public Health/Epidemiology by the Collective Health Institute of the Federal University of Bahia (UFBA). He is a peer reviewer for several medical journals, and an academic mentor for postgraduate and doctorate students in Epidemiology. His current research interests are Epidemiology/Public Health and Nutrition, with an emphasis on Epidemiology and Prevention of HIV/AIDS and Other Sexually Transmitted Infections, Women's and Children's Health, Evidence-based Medicine, and Health Inequalities. Webpage.
Research interests: Physical activity, exercise, aging, hypertension, type 2 diabetes, reproducibility, research integrity
Daniel received his BSc in kinesiology (exercise sciences) from the Universidade Federal do Rio Grande do Sul (UFRGS). Having a primary interest in exercise interventions in clinical conditions, he studied physical activity in context of aging, cardiovascular disease, and type 2 diabetes during his MSc and PhD. He established two main interests during a postdoctoral fellowship: (1) clinical trials and systematic reviews/meta-analyses of lifestyle interventions; and (2) meta-research in science dissemination practices. Daniel is based in Porto Alegre (Brazil), working as an assistant professor of research methods, chief of the clinical research center at the Hospital de Clínicas de Porto Alegre, and an academic mentor for graduate students and postdocs. Webpage.
Research interests: diabetes, hyperlipidemia, dementia, stroke, atherosclerosis, acne, primary care, routine healthcare data, pharmacoepidemiology, systematic review and meta-analysis
Zhirong completed a PhD in the Department of Public Health and Primary Care at University of Cambridge. He also holds a bachelor's degree in medicine and master's degrees in epidemiology and in primary care research. He was a research fellow in the Department of Population Medicine at Harvard University in 2018. Before his PhD, he worked as a biostatistician in Shantou-Oxford Clinical Research Unit and then as a research associate in Peking University School of Public Health. His current research interests are in the use of routine healthcare data and evidence synthesis to inform the management of cardiovascular diseases, dementia and diabetes. Webpage.
Research interests: malaria, sepsis, antimicrobial resistance, paediatrics, quality of care, dehydration, malnutrition
Sam (MBChB, MMED (Paediatrics), Dphil) is a principal investigator at the KEMRI/Wellcome Trust Programme, Nairobi, a honorary lecturer at the Department of Paediatrics, University of Nairobi, Kenya, and a Visiting Research Fellow, University of Oxford, United Kingdom. He is a consultant paediatrician and clinical epidemiologist with research interest in severe febrile illnesses in children. His research spans understanding epidemiology of severe febrile illnesses in children, clinical trials, investigation of effectiveness of treatments in children admitted with severe illnesses, antimicrobial resistance, application of machine learning techniques and data science for biomedical clinical data, and in design of appropriate digital solutions for identification and management of paediatric sepsis. He runs an inpatient surveillance to answer questions of safety following introduction of new interventions, such a recently introduced malaria vaccine in Kenya, and to understand how compliance with clinical guidelines affect in-hospital survival. He is involved in teaching and supervision of postgraduate and doctorate students, is a peer reviewer for several medical journals and research funders and provides technical consultation to global bodies involved in health such as the World Health Organization (WHO). Webpage.
Research interests: modeling, infectious diseases, outbreaks, COVID-19, Bayesian, infection control, reproduction number, emerging infectious diseases, vaccines, public health, global health
Andrei R. Akhmetzhanov graduated from Moscow Institute of Physics and Technology, Russia and decided to pursuit his academic career in theoretical epidemiology and public health. With background in applied mathematics and physics, he found himself lucky to work with many profound scholars in biology, medicine, and computer sciences. He trained himself to deal with more applicable research involving data analysis and statistical inference. His expertise lies in mathematical modeling of infectious diseases with particular interest on outbreak investigation and identification of epidemiological parameters for emergent infectious diseases. In the past ten years, he lived in four different countries (Canada, France, Japan, Taiwan), and finally resided in Taiwan. Currently he is an assistant professor in Global Health Program and Institute of Preventive Medicine and Epidemiology at National Taiwan University College of Public Health in Taipei. While working in Japan, he was a volunteer member of the national COVID-19 task force in 2020. During 2021-2022, he interacted with Taiwan Centers for Diseases Control on similar matters. Webpage.
Research interests: Cholera, infectious diseases, public health, epidemiology
Dr. Godfrey Bwire (MBChB, MPH, PhD) is a medical doctor, researcher and a policymaker. Godfrey is the head of the division of public health emergency preparedness and response of the Republic of Uganda Ministry of Health. Godfrey is also a research fellow in the department of Community Health and Behavioral Sciences, Makerere University School of Public Health. Godfrey’s research interests are on infectious diseases, public health and cholera. Godfrey et al. identified a new Vibrio Cholerae transmission event lineage (T13) from South Asia to East Africa, PMID: 29864113. Godfrey has an excellent peer-review record. Webpage.
Research interests: Infectious diseases, primary immunodeficiency, immunology
Dr Edwards received her BSc (Hons) in Applied Biomedical Science at the University of Wales Institute Cardiff (UWIC), prior to completing a PhD at Cardiff University in the UK. She relocated to Australia in 2011. She has since conducted research at the QIMR Berghofer Medical Research Institute, Garvan Medical Research Institute and is currently a Postdoctoral Fellow at Monash University in Melbourne. Emily’s research focuses on the cellular and molecular pathways that underlie Primary Immunodeficiency, including identifying molecular and cellular patterns associated with viral infection, autoimmunity and gastrointestinal disease in these patients. Her research has identified new genetic causes of Primary Immunodeficiency, susceptibility to EBV and how these genetic defects influence immune pathway function, memory B and T cell function, and drive clinical disease. She is currently working to further understand primary immunodeficiencies, in order to examine the immune pathways altered in these diseases to better inform patient diagnosis and treatment. Webpage.
Research interests: Cellular and humoral immunology of parasite and viral infections; Vaccine candidate discovery, design and testing; Pathogen biology
Dr. Kwadwo Asamoah Kusi is a Senior Research Fellow in the Immunology Department of Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana. He started his career at NMIMR in 2012 after graduating with a PhD in Medicine from Leiden University Medical Centre, based on his work at Biomedical Primate Research Centre in Rijswijk, The Netherlands. His research has been on assessing pathogen-induced cellular and humoral immune responses, with a special focus on Plasmodium falciparum. He is currently working on identifying HLA-restricted epitopes that elicit protection-associated T cell responses in individuals with a natural history of P. falciparum infection. He is principal investigator of an EDCTP2-funded Senior Fellowship that is investigating the impact of hepatitis B and Plasmodium co-infections on the liver. He is lead Immunologist on an on-going phase Ib clinical trial of an Inovio Pharmaceuticals Lassa fever vaccine at NMIMR as well as on a combined trial of measles/COVID-19 live vaccines for cross protection in Ghana, as part of a multi-centre trial under the CROWN CORONATION umbrella. He has on-going studies on multi-allele vaccine formulation strategies that aim to overcome the strain-dependent effects of polymorphisms in immunogenic Plasmodium antigens on antigen-specific immune responses. Webpage.
Research interests: infectious disease epidemiology; infectious disease modeling; vaccine; health economics
Kathy Leung received her BS in Biological Sciences from School of Life Sciences and BA in Economics from China Center for Economic Research at Peking University, MPhil, and PhD from School of Public Health at The University of Hong Kong. In recent years, Kathy is interested in mathematical modelling of a wide range of diseases such as influenza, MERS, COVID-19, hand-foot-and-mouth disease, HPV, cervical cancer, colorectal cancer, and breast cancer. She also conducts epidemiological and economic evaluations of disease intervention strategies, such as HMFD vaccination, public health and social measures against COVID-19, and risk-based breast cancer screening. Leveraged on the latest development of data science, she also uses machine learning to interpret SARS-CoV-2 genomic data and participates in the development of tools to tackle misinformation about COVID-19 vaccination with natural language processing. Kathy is a member of HKU’s COVID-19 Response Team and has contributed to the earliest studies about COVID-19 epidemiology. She is an investigator of the Laboratory of Data Discovery for Health (D²4H) at the Hong Kong Science Park. Webpage.
Research interests: Health economics, infectious disease modelling, TB, HIV, cost-effectiveness analyses, choice modelling
I am a health economist specialising in the prevention of infectious diseases, working at the interface of mathematical modelling and health economics. I enjoy the challenge of representing complex human behaviours in models and understanding how to encourage equitable and efficient health. My work mainly focuses on HIV and TB. Webpage.
Research interests: Sporotrichosis, subcutaneous mycoses, fungal infections, epidemiology, viral hepatitis (A, B, C, D and E), dengue, SARS-CoV-2
Max is a PhD Researcher at the Universidad Peruana Cayetano Heredia in Peru. He has a BSc and completed a Master’s degree in Public Health at the Universidad Nacional Mayor de San Marcos in Peru. He is a professor and researcher in epidemiology and infectious diseases. His research expertise includes evidence synthesis, clinical and epidemiological aspects of fungal infections and infectious diseases. He has published several articles in peer-reviewed journals that explore clinical and epidemiological aspects of sporotrichosis, chromoblastomycosis, and superficial mycoses, and infectious diseases (HAV, HBV, HCV, dengue, SARS-CoV-2, and cutaneous leishmaniosis). He also works in managing funds in research and improving evaluation and selection processes in Peru. He is currently the Associate/Academic Editor and Editorial Board Member for various international journals. He also acts as an associate editor for the journals of BMC Cancer and BMC Infectious Diseases since May 2019. He serves as peer reviewer for various leading journals, and is a Top Peer Reviewer in Publons, Web of Science. Webpage.
Research Interests: Infectious disease epidemiology, mathematical modelling, Bayesian statistics, machine learning, serology, immunology, arbovirus, dengue, influenza, SARS-CoV-2
Dr. Lin Wang is a Research Associate in the Department of Genetics, University of Cambridge. Before joining Cambridge, he was a chargé de recherché in the Mathematical Modelling of Infectious Disease Unit at the Institute Pasteur, and a postdoctoral fellow in the WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, the University of Hong Kong. He has a PhD in Electronic Engineering from Fudan University, MSc and BSc in Physics from Nankai University and Southeast University, respectively. His research interests include infectious disease epidemiology, mathematical modelling, Bayesian statistics, machine learning, serology, immunology, and viral evolution, with applications to arbovirus (e.g. dengue) and emerging diseases (e.g., pandemic influenza, SARS-CoV-2). Webpage.
Research interests: Tuberculosis, TB/HIV, community-based interventions, patient-centered care, implementation science, mixed-methods research, global health
Courtney Yuen, PhD, is an epidemiologist in the Division of Global Health Equity at the Brigham and Women’s Hospital and an assistant professor in the Department of Global Health and Social Medicine at Harvard Medical School in Boston, MA, USA. Previously, she worked in the Division of Tuberculosis Elimination at the U.S. Centers for Disease Control and Prevention. She conducts implementation science research on community-based models for tuberculosis case-finding preventive treatment, as well as epidemiologic modeling to inform tuberculosis diagnosis and prevention policies. Her research has been funded by U.S. National Institute of Health, the Bill and Melinda Gates Foundation, the Patient-Centered Outcomes Research Institute, and the Charles H. Hood Foundation. Webpage.
Research interests: Genomics, atherosclerosis, blood traits, epidemiology, ancestry, diversity, gene expression, TWAS, GWAS, somatic clonality
Chani Hodonsky is a postdoctoral research associate in the University of Virginia Center for Public Health Genomics. She completed her PhD in Genetic Epidemology at the UNC Chapel Hill Gillings School of Public Health in 2019, where her dissertation involved identifying and fine-mapping genetic associations with red blood cell traits in the ancestrally diverse PAGE Study. Currently, Chani studies the role of genetic variation and gene expression changes in the development and progression of atherosclerosis in Clint Miller's lab at UVA. This work involves both population-based association studies (eQTL and related fine-mapping in coronary artery tissue) and single-cell-based analyses of individual human samples (somatic clonality in coronary artery disease). In addition to her work in the Miller Lab, Chani peer reviews for several academic journals, and is an active member of the American Society for Human Genetics and American Heart Association. Webpage.
Research interests: Systems biology; Genomic Medicine; Omics integration; Modeling; Microbiome; Biomarker
Boyang is scientific data developer at BioInnovation Institute, Copenhagen. He received the B.S. and M.S. from the Huazhong Agricultural Unuvrsity in China, and Ph.D. of genomics and bioinformatics from the Aix-Marseille Univrsity in France. His research aims to uncover the metabolic basis linked to human disease by using both experimental and computational approaches. Currently, his work focused on the discovery of biomarkers of human diseases with muti-omics data and machine learning approaches. Webpage.
Research interests: multi-omics; genetic epidemiology; bioinformatics; biostatistics
Dr. Chao Xu is an Assistant Professor at the University of Oklahoma Health Sciences Center. He is a member of the Stephenson Cancer Center Biostatistics and Research Design Shared Resource. He received his PhD in Biostatistics from Tulane University, US. He has a broad background in statistical genetics, biostatistics, bioinformatics, and genetic epidemiology, with specific training and expertise in genetic and genomic studies of complex diseases, such as the osteoporosis and cancer. Webpage.
Research interests: Cognitive and Affective Neurosciences, Psychiatry, Neuropsychology, Psychotherapy
Born in 1965 in Greece, I obtained my MD degree in the University of Athens in 1989 before completing a full training on psychiatry and psychotherapy in London and Geneva as well as postdoc training in Paris (La Pitié-Sâlpetrière Hospital, Federation of Neurology). My psychiatric education combined early exposure to neurobiology and classical psychoanalytic training. In 1998, aged 33 years, I have been appointed as associate professor and medical head of the Division of Geriatric Psychiatry of the University Hospitals of Geneva. Later on (2004) I obtained the position of full tenured professor of Psychiatry in the University of Geneva. From 2003 to 2011, I also assumed a parallel position of full professor of Old Age Psychiatry in the University of Lausanne in order to promote the academic careers of junior staff locally. An important part of my duties concerns the management and organization of psychiatric care for the Geneva state as Chairman of the Department of Mental Health and Psychiatry (2005-2015). In addition to this hospital position, I have been for 8 years vice dean of the Faculty of Medicine in the University of Geneva having the responsibility of postgraduate and continuous education. To date, I have the responsibility of forensic psychiatry for law ordered treatments in the Geneva County. I have been also elected in the Executive Committee of the Council of Chiefs of Divisions in University Hospitals of Geneva.
My research field was initially that of the functional neuroanatomy of dementing conditions and may be illustrated by a series of clinico-pathological studies aiming to determine the relative weight of each aging-related lesion in cognitive deterioration. This work was made in close collaboration with the Department of Geriatrics and the Division of Neuropsychiatry of the University Hospitals of Geneva and the Department of Neuroscience of the Mount Sinai Hospital, NY. These ex vivo observations on neuropathological markers of dementia have been at the origin of an in vivo complement focusing on the identification of predictive markers of rapid cognitive decline in elderly controls. Lately, a new research program from my lab focuses on the fMRI and EEG correlates of human empathy in line with my current hospital position.
Research interests: neurodegenerative diseases (with special expertise in Amyotrophic lateral sclerosis, Frontotemporal Dementia and Charcot–Marie–Tooth disease), regenerative medicine, translational research
Dr. Wenting Guo is a neuroscientist and postdoctoral research associate in both VIB-KU Leuven Center for Brain & Disease Research and KU Leuven Stem Cell Institute (SCIL) of KU Leuven University in Belgium. She received BS in Biological sciences and BA in English language and literature from Shanxi University in China, MSc in Genetics from Shanghai Jiao Tong University in China, PhD in Biomedical sciences from KU Leuven University in Belgium. Dr. Guo’s research focus on building up in vitro/in vivo models, studying disease pathogenesis, and finding new therapeutic targets for neurodegenerative disorders with specialized expertise in Amyotrophic Lateral Sclerosis (ALS), Charcot–Marie–Tooth (CMT) disease and Frontotemporal Dementia (FTD). She has published a series of peer-reviewed articles in high impact journals and own several research grants, fellowships, and prizes. Her research article on axonal transport defects in ALS patient derived motor neurons has been ranked as top ten most trendy articles in PubMed in the first week online and has been widely reported by social media including Alzforum, ALS News Today et al. Aside from research, Dr. Guo serves as external expert for two European Union's Horizon research and innovation programme funded projects to promote collaboration and communication between Europe and China, she also works as reviewer board, guest associate editor and invited reviewer for several international journals. Webpage.
Research interests: Brain stimulation; neuroimaging; clinical trial; predictors; aging
Dr. Lu currently works as Research Assistant Professor and Core Member of Neuromodulation Lab and Dementia Research Unit at the Department of Psychiatry, The Chinese University of Hong Kong (CUHK). She is also a Honorary Professor at the Affiliated Brain Hospital of Guangzhou Medical University and the Board Member of BrainConnects and The Brain X. Dr. LU’s research interests focusing on the development of personalized image-guided neuromodulation and using this technique to decode complex cognitive function and treat brain disorders. Dr. LU has published more than 20 SCI papers as first and corresponding author, including JNNP, JAD, JMADA. Some of her papers win the Gold Award of the Asian Oceanian Congress of Neurology. Webpage.
Obstetrics and Gynecology
Research interests: Causal inference for observational studies, Bayesian modeling, Meta-Analysis, Categorical Data Analysis, skewed link function modeling, Design and analysis of Clinical Trials, Statistical Modelling, Survival Data Analysis
I am an assistant professor of Biostatistics at Babol University of Medical Sciences in Iran, and senior biostatistician at Imperial College London. I was granted my MSc and Ph.D. degree from Tehran University of Medical Sciences (TUMS) in 2016. I am also a member of the Ethical committee for biomedical research at Islamic Azad University. I was working as a Biostatistician at Royan Biomedical and Stem cells Institute from 2009 to 2018. The institute is a reputable and very well-known organization for stem cells and biomedicine research with a significant level of innovations and global achievements, hence I had the opportunity to be involved in the design of research plans, data management, data analysis and interpretation of the results of many major projects which was a great experience and learning opportunity for me to work as a Biostatistician in the research teams under supervision of the well-known specialists and academic entities in medical and biology fields. I have published several peer-reviewed papers in international ranked journals in a variety of academic disciplines, including medicine, public health, biology, genetics, biomedicine, human reproduction and psychology. I have outstanding experience in working with statistical software programmes including R, SAS, STATA, SPSS, PASS, GraphPad prism, Bugs. Webpage.
Research interests: global health, maternal and child health
Dr. Kimiyo Kikuchi is a lecturer at the Faculty of Medical Sciences, Kyushu University, and specializes in global health, maternal and child health, and the social aspect of HIV. Dr. Kikuchi studied at the Graduate School of Medicine, the University of Tokyo, and obtained Ph.D. in Health Sciences, with research on the adherence of antiretroviral therapy among HIV-positive orphans and non-orphans in Rwanda (mixed methods study). Dr. Kikuchi worked as a consultant of official development assistance under Japanese government projects on maternal health, school health, and water and sanitation in Africa, the Middle East, and South Asia. Dr. Kikuchi settled in the University of Tokyo as an assistant professor in 2012 and worked as the primary researcher of Ghana's EMBRACE project to ensure the continuum of care in maternal and child health, which embodies the "New International Health Policy 2011-2015" of the Japanese government. Then, in 2016, Dr. Kikuchi moved to Kyushu University and launched a project to improve the continuum of care on maternal and child health in Bangladesh using a telemedicine system. Webpage.
Research interests: Environmental epidemiology; climate change and health; air pollution and health; built environment and health; cohort study; time-series study
Dr. Sun is currently a Research Scientist in Environmental Health at Boston University School of Public health. Prior to his current position, he completed two years of postdoctoral training at Brown University School of Public Health. He obtained a Ph.D. is in Epidemiology and Biostatistics from the University of Hong Kong (2017). His research focuses on climate change and health and, in particular maternal and child health. He applies sophisticated statistical approaches to large complex national data sets to inform public health. Webpage.
Research interests: Pregnancy complications, gestational diabetes, gestational hypertension, preterm birth, nutrition, epidemiology, obesity, children
Yeyi Zhu, PhD, is a Research Scientist II (equivalent to Associate Professor) at Kaiser Permanente Northern California Division of Research and adjunct faculty at Department of Epidemiology and Biostatistics, University of California, San Francisco. Dr. Zhu's research interests are at the interface of disease etiology and prevention strategies in the arena of women's and children's health across the lifespan. She applies a life course approach to examine the developmental origins of cardiometabolic impairments of offspring exposed to nonoptimal intrauterine environment by integrating 'omics technologies, high-dimensional electronic health records, and "big data" analytics tools. Her research aims to inform upstream preventive strategies to interrupt the vicious intergenerational cycle of obesity and diabetes and its related comorbidities across the lifespan. Dr. Zhu's research is sponsored by grants from the National Institute of Diabetes and Digestive and Kidney Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Heart, Lung, and Blood Institute. Webpage.
Research interests: cancer, epidemiology, obesity, diet, disparities, rural, implementation science
I am a cancer epidemiologist, with a focus on understanding how lifestyle factors, such as diet, physical activity, and obesity influence cancer risk and survival. My research explores rural, socioeconomic, and racial/ethnic disparities and investigates social determinants of behavioral risk factors contributing to observed disparities. As a rural community-based researcher, my research is shifting toward translational work including using dissemination and implementation science approaches to effectively incorporate evidence-based interventions into underserved settings. Webpage.
Research interests: biomedical engineering, lasers & optics, physics, and Radiology. Computer assisted quantification, Cancer, Translational medicine, Bioinformatics, Radiomics, Radiation oncology, Medical Imaging (MRI, CT, Ultrasound, Digital imaging), Nanoparticles
Dr. Jaidip Jagtap received his both M.Sc. and Ph.D. degrees in Physics from the University of Pune in 2008 and from IIT Kanpur, India in 2015, respectively. He has completed 5 years of postdoctoral work at the Medical College of Wisconsin, Milwaukee, USA in the Biomedical Engineering Department on developing an NIR-SWIR imaging tool to image and analyze the altered vascular/lymphatic functions in small animal models due to impact from tumor or irradiation. Also developed a nanoparticle mediated therapeutic tool for diagnostic and therapeutic study. Currently, Dr. Jagtap is a research staff in Radiology at Mayo Clinic Rochester, working with artificial intelligence, machine learning, and deep learning to develop models and assist radiologist in decision making. His study involved various clinical data (MRI, CT, ultrasound, histopathology) from the kidney, skin, nerves, etc. He is the author of over 40 scientific papers published in international peer-reviewed journals, 10 book chapters, and several congress proceedings. He has peer-reviewed 70+ articles for various international scientific journals and also given invited talks and oral presentations on various platforms. Webpage.
Research interests: Genetic epidemiology, epigenetic epidemiology, twin research, family research, cancer risk prediction, breast cancer
Dr Shuai Li is a Research Fellow at the Centre for Epidemiology and Biostatistics, The University of Melbourne. Dr Li is trained in medicine and epidemiology, with a Bachelor of Medicine degree and a Master of Science degree obtained in Peking University, and a PhD degree obtained in the University of Melbourne in 2018. From 2018 to 2020, he worked at the Centre for Cancer Genetic Epidemiology, Cambridge University. Dr Li’s research interests include genetic and epigenetic epidemiology of cancers, twin and family research, and cancer risk modelling. Webpage.
Research interests: Cancer epidemiology, cancer prevention, cancer risk factors, cohort studies, metabolomics, biomarkers, omics technologies, nutrition
Joseph is a molecular epidemiologist and researcher at the French National Institute of Health and Medical Research (Inserm). His main focus is understanding cancer, metabolic diseases and their risk factors, such as nutrition and environmental exposures, in the context of primary prevention. He aims to bring together traditional epidemiology and molecular techniques such as -omics technologies to aid the understanding of these diseases and contribute to their prevention.
Initially trained as a laboratory bioanalyst, he spent the early part of his career operating and maintaining instruments such as mass spectrometers for studies of various design on nutrition and health. This led him to specialise in metabolomics and these days he has traded the laboratory bench for epidemiological data analyses and programming. His recent research pertains to colorectal and breast cancer, with large metabolomics datasets frequently put to use. He is a proponent of reproducible research and a fan of open-source code and version control. Webpage.
Research interests: NSCLC; Liquid biopsy; Immunotherapy; SCLC
Dr. Russo is a board-certified medical oncologist with interest in thoracic malignancies, immunotherapy and liquid biopsies.
Dr. Russo degreed as M.D. at the University of Messina (Italy) and there he completed his residency in Medical Oncology. He had his PhD in 2019 in Medical and Surgical Biotechnologies at the University of Messina, with a research project on the role of liquid biopsies as predictive biomarkers to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). During his PhD, Dr. Russo joined as Visiting Researcher the Division of Thoracic Medical Oncology and Early Clinical Trials at the University of Maryland Medical Center, Greenebaum Comprehensive Cancer Center (Baltimore, USA).
From February 2020 he joined the Medical Oncology Unit of the A.O. Papardo (Messina, Italy) as medical oncologist, with focus on thoracic malignancies.
He is member of several national and international scientific societies, including the International Association for the Study of Lung Cancer (IASLC), the Italian Association of Thoracic Oncology (AIOT), the Italian Association of Medical Oncology (AIOM) and the European Society for Medical Oncology (ESMO). Dr. Russo took part to the Executive Board of the Sicilian Section of the Italian Association of Medical Oncology (AIOM) for the years 2015-2019.
Dr. Russo is co-author of more than 70 publications in peer-reviewed international journals, three book chapters and he is actively involved in clinical research in advanced NSCLC. Webpage.
Research interests: Malignant glioma; Neurofibromatosis; iPS cells; Neural stem cell; Gene therapy; Immunotherapy; Skull base surgery
My clinical and research interests focus on neurosurgical approaches to patients with brain tumors. I am dedicated to management of patients with malignant glioma, sporadic schwannoma and neurofibromatosis type 2. As a neurosurgeon in Keio University, Japan, I specialize in skull base techniques for posterior cranial fossa tumors.
Active areas of research include stem cell-based gene therapy using iPS cells for the treatment of the central nervous system tumors and regenerative medicine. I serve as a PI leading multiple preclinical studies evaluating the treatment effect of genome-edited iPS cells utilizing orthotopic immunocompetent glioblastoma models and plan to transcribe into novel gene therapy clinical studies with glioblastoma patients. Another area of my research involves the role of anti-angiogenic immunotherapy for the treatment of unresectable benign tumors including neurofibromatosis type 2. Webpage.
Research interests: Biotherapy, Immunotherapy, Liquid biopsy, Tumor microenvironment, Biomarkers, Metastasis, Cancer stem cell
I am a Research Associate in the Department of Immunology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. I am trained in Bioengineering, with a Bachelor degree obtained in China Agricultural University, and a PhD in Biochemistry and Molecular Biology obtained in the Beijing Normal University in 2018. My research focuses on cancer biotherapy and immunotherapy, especially the application of oncolytic viruses. Similarly, I am also interested in the influence of the tumor microenvironment on tumor therapy. In addition, part of my work has focused on liquid biopsy, especially clinical applications of circulating tumor cells. Webpage.